JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patien

Follow JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patien
Share on
Copy link to clipboard

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis…

JAMA Network


    • May 29, 2025 LATEST EPISODE
    • monthly NEW EPISODES
    • 14m AVG DURATION
    • 125 EPISODES


    More podcasts from JAMA Network

    Search for episodes from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patien with a specific topic:

    Latest episodes from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patien

    New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance

    Play Episode Listen Later May 29, 2025 18:54


    Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD. Related Content: New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance

    Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury

    Play Episode Listen Later Apr 24, 2025 12:23


    Interview with Shruti Gupta, MD, MPH, author of Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury. Hosted by Vivek Subbiah, MD. Related Content: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury

    Accelerated Aging in Survivors of Childhood Cancer

    Play Episode Listen Later Mar 20, 2025 19:19


    Interview with Jennifer M. Yeh, PhD, and Lisa R. Diller, MD, authors of Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions. Hosted by Vivek Subbiah, MD. Related Content: Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions On Accelerated Aging—A Phenomenon in Survivors of Childhood Cancer

    Academic-Community Partnership and Deaths in Promyelocytic Leukemia

    Play Episode Listen Later Feb 27, 2025 18:46


    Interview with Anand P. Jillella, MD, author of Academic-Community Partnership and Deaths in Promyelocytic Leukemia: The Nonrandomized ECOG-ACRIN EA9131 Trial. Hosted by Vivek Subbiah, MD. Related Content: Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality

    Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

    Play Episode Listen Later Jan 30, 2025 11:55


    Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD. Related Content: Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy

    Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020

    Play Episode Listen Later Dec 5, 2024 16:08


    Interview with Katrina A. B. Goddard, PhD, author of Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020. Hosted by Vivek Subbiah, MD. Related Content: Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020

    Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

    Play Episode Listen Later Nov 21, 2024 18:46


    Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

    Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

    Play Episode Listen Later Oct 24, 2024 20:41


    Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

    Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer

    Play Episode Listen Later Sep 5, 2024 17:15


    Interview with Eileen M. O'Reilly, MD, author of Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer. Hosted by Vivek Subbiah, MD. Related Content: Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer

    Identification of Immune Checkpoint Inhibitor–Induced Diabetes

    Play Episode Listen Later Aug 29, 2024 14:36


    Interview with Michelle Rengarajan, MD, PhD, author of Identification of Immune Checkpoint Inhibitor–Induced Diabetes. Hosted by Vivek Subbiah, MD. Related Content: Identification of Immune Checkpoint Inhibitor–Induced Diabetes

    Neoadjuvant Exercise Therapy in Prostate Cancer

    Play Episode Listen Later Jul 18, 2024 19:01


    Interview with Lee W. Jones, PhD, author of Neoadjuvant Exercise Therapy in Prostate Cancer: A Phase 1, Decentralized Nonrandomized Controlled Trial. Hosted by Vivek Subbiah, MD. Related Content: Neoadjuvant Exercise Therapy in Prostate Cancer

    Endometrial Thickness as Diagnostic Triage for Endometrial Cancer in Black Individuals

    Play Episode Listen Later Jun 27, 2024 15:04


    Interview with Kemi M. Doll, MD, MSCR, author of Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals. Hosted by Vivek Subbiah, MD. Related Content: Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals

    T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

    Play Episode Listen Later Apr 18, 2024 19:57


    Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD. Related Content: T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

    Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time

    Play Episode Listen Later Mar 21, 2024 25:53


    Interview with Tobias Janowitz, MD, PhD, and Karen Winkfield, MD, PhD, authors of Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time. Hosted by Vivek Subbiah, MD. Related Content: Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time

    Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer

    Play Episode Listen Later Feb 29, 2024 14:26


    Interview with José P. Leone, MD, author of Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer. Hosted by Nora L. (Mary) Disis, MD. Related Content: Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer

    Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

    Play Episode Listen Later Jan 4, 2024 17:31


    Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L. (Nora) Disis, MD. Related Content: Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

    Atezolizumab in Combination With Carboplatin in Metastatic TNBC

    Play Episode Listen Later Dec 14, 2023 18:18


    Interview with Jennifer A. Pietenpol, PhD, Brian D. Lehmann, PhD, and Vandana G. Abramson, MD, authors of Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial. Hosted by Mary L. (Nora) Disis, MD. Related Content: Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer

    Shorter-Course Radiotherapy for Prostate Cancer

    Play Episode Listen Later Oct 5, 2023 15:14


    Interview with Daniel E. Spratt, MD, author of Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer. Hosted by Jack West, MD. Related Content: Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer

    Sentinel Lymph Node Biopsy vs No Axillary Procedure in Small Node-Negative Breast Cancer

    Play Episode Listen Later Sep 21, 2023 19:02


    Interview with Oreste Davide Gentilini, MD, author of Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes

    A Geospatial Analysis of Disparities in Access to Oncofertility Services

    Play Episode Listen Later Aug 10, 2023 23:12


    Interview with Kara N. Goldman, MD, author of A Geospatial Analysis of Disparities in Access to Oncofertility Services. Hosted by Jack West, MD. Related Content: A Geospatial Analysis of Disparities in Access to Oncofertility Services

    Integrated Clinical-Molecular Classification of Colorectal Liver Metastases

    Play Episode Listen Later Jul 20, 2023 16:29


    Interview with Sean P. Pitroda, MD, author of Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Integrated Clinical-Molecular Classification of Colorectal Liver Metastases

    US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020

    Play Episode Listen Later Jun 29, 2023 17:16


    Interview with Sophia C. Kamran, MD, author of US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020. Hosted by Jack West, MD. Related Content: US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020

    Oncolytic Viral Immunochemotherapy in Patients With Ovarian Cancer

    Play Episode Listen Later May 25, 2023 15:07


    Interview with Robert W. Holloway, MD, and Sarfraz Ahmad, PhD, authors of Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial. Hosted by Jack West, MD. Related Content: Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer

    Radiosurgery of Spine Metastasis—NRG/RTOG 0631 RCT Final Results

    Play Episode Listen Later Apr 20, 2023 14:15


    Interview with Samuel Ryu, MD, author of Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine

    Pathologic Complete Response and Clinical Outcomes in Soft Tissue Sarcoma

    Play Episode Listen Later Mar 30, 2023 14:03


    Interview with Dian Wang, MD, author of Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials. Hosted by Jack West, MD. Related Content: Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy

    Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma

    Play Episode Listen Later Feb 16, 2023 16:40


    Interview with Laura A. Bolte, MSc, Geke A. P. Hospers, MD, PhD, and Rinse K. Weersma, MD, PhD, authors of Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma. Hosted by Jack West, MD. Related Content: Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma

    Adoption of Innovative Therapies Across Oncology Practices

    Play Episode Listen Later Jan 5, 2023 21:08


    Interview with Nancy L. Keating, MD, MPH, author of Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy. Hosted by Jack West, MD. Related Content: Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy

    Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy

    Play Episode Listen Later Dec 8, 2022 18:37


    Interview with Marco Del Chiaro, MD, PhD, author of Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. Hosted by Jack West, MD. Related Content: Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy

    Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma

    Play Episode Listen Later Nov 17, 2022 18:28


    Interview with Linda M. Liau, MD, PhD, author of Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. Hosted by Jack West, MD. Related Content: Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

    Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma

    Play Episode Listen Later Oct 27, 2022 12:16


    Interview with Olivier J. van Not, MD, and Karijn P. M. Suijkerbuijk, MD, PhD, authors of Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma. Hosted by Jack West, MD. Related Content: Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma

    Prostate-Specific Antigen Screening Rates and Metastatic Prostate Cancer Incidence in the VHA

    Play Episode Listen Later Oct 24, 2022 16:36


    Interview with Brent S. Rose, MD, author of Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities. Hosted by Jack West, MD. Related Content: Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities

    Therapy and Survival Patterns in Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy

    Play Episode Listen Later Aug 18, 2022 15:26


    Interview with Hagen F. Kennecke, MD, author of Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy. Hosted by Jack West, MD.

    Global Association of COVID-19 Pandemic Measures With Cancer Screening

    Play Episode Listen Later Jul 7, 2022 12:53


    Interview with Paolo Boffetta, MD, author of Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis. Hosted by Jack West, MD.

    A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief

    Play Episode Listen Later Jul 5, 2022 22:07


    In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science. Related Content: The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (video) A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (audio)

    conversations phd chief md responsibility nobel domingo jama new editor harold varmus kirsten bibbins domingo bibbins domingo related content the urgency do more my commitment jama's new editor in chief
    High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade

    Play Episode Listen Later Jun 16, 2022 19:09


    Interview with Mark M. Awad, MD, PhD, author of Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. Hosted by Jack West, MD.

    Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality

    Play Episode Listen Later May 19, 2022 14:06


    Interview with Lars Björnebo, MSc, and Anna Lantz, MD, PhD, authors of Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality. Hosted by Jack West, MD.

    Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

    Play Episode Listen Later Apr 28, 2022 23:31


    Interview with David Anthony Palma, MD, PhD, and Anthony C. Nichols, MD, authors of Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial Hosted by Jack West, MD.

    Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer

    Play Episode Listen Later Mar 17, 2022 20:09


    Interview with Kenneth L. Kehl, MD, MPH, author of Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216). Hosted by Jack West, MD.

    Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer

    Play Episode Listen Later Feb 17, 2022 15:22


    Interview with Ruth C. Carlos, MD and Gelareh Sadigh, MD, authors of Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial. Hosted by Jack West, MD.

    Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy

    Play Episode Listen Later Jan 20, 2022 18:16


    Interview with Laurent Dercle, MD, PhD, author of Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis.  Hosted by Jack West, MD.

    Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

    Play Episode Listen Later Dec 23, 2021 22:38


    Interview with Robert J. Motzer, MD, author of Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma. Hosted by Jack West, MD.

    Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer

    Play Episode Listen Later Nov 18, 2021 23:56


    Interview with Emmanouil Fokas, MD, DPhil, author of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. Hosted by Jack West, MD.

    Claim JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patien

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel